Experimental and Clinical Evaluation in Man of Hexamethonium (C6), A New Ganglionic Blocking Agent
In this follow-up to an earlier article by several British researchers, Finnerty and Freis confirmed that Hexamethonium acted
longer and produced a greater degree of sympathetic blockade than tetraethylammonium, a ganglion-blocking agent that was found
to be a poor treatment for chronic hypertension.
Presented in part before the national meeting of the American Federation of Clinical Research, Atlantic City, New Jersey,
Number of Image Pages:
9 (1,204,030 Bytes)
1950-12 (December 1950)
Finnerty, Frank A. Jr
Freis, Edward D.
Periodical: Finnerty, Frank A. Jr, and Edward D. Freis. "Experimental and Clinical Evaluation in Man of Hexamethonium (C6), A New
Ganglionic Blocking Agent." Circulation II, 6 (December 1950): 828-836. Article. 9 Images.
[American Heart Association]
This item is in the public domain. It may be used without permission.
Medical Subject Headings (MeSH):
The Veterans Administration Hospital and Georgetown University School of Medicine, 1949-1964